What are the best mental health apps?
This blog post has been written by the person who has mapped the mental health tech market in a clean and beautiful presentation
Mental health technology has evolved from experimental wellness apps to a $3.1 billion investment magnet projected for 2026.
The sector achieved renewed investor confidence in 2024-2025 with FDA-cleared digital therapeutics, AI-powered personalized therapy, and major corporate acquisitions reshaping the landscape. And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.
Summary
The mental health app market rebounded strongly in 2024-2025 with $2.7 billion in funding, driven by AI-native platforms achieving 20%+ retention rates and FDA-cleared digital therapeutics creating new reimbursement pathways. Major players like Calm ($300M revenue) and Headspace ($195M) still dominate consumer subscriptions, while B2B platforms capture employer contracts at $5-11 per member monthly, with prescription digital therapeutics now billable under new CMS codes at ~$1,700 per treatment course.
| Category | Leading Players | 2024-25 Metrics | Key Developments | Revenue Model |
|---|---|---|---|---|
| Consumer Meditation | Calm, Headspace, Insight Timer | $300M, $195M, $48M revenue respectively | Insight Timer leads retention at 16% vs Calm's 8.3% | Freemium + $69.99/yr subscriptions |
| Teletherapy Platforms | BetterHelp, Talkspace, UpLift | $250M, $138M revenue; UpLift acquired for $30M | Teladoc acquired UpLift to add insurance billing | $65-95/week therapy plans |
| AI-Powered Therapy | Pathos, Woebot, Wysa | Pathos raised $365M Series D; 23% retention | AI sentiment analysis driving personalization | Employer SaaS + direct consumer |
| Digital Therapeutics | Rejoyn, MamaLift Plus, SleepioRx | First FDA-cleared apps for depression, PPD | New CMS billing codes worth ~$1,700/course | Prescription reimbursement model |
| Corporate Wellness | Lyra Health, Spring Health, Modern Health | $5-11 PEPM pricing; 18-25% margins | Value-based contracts with outcome guarantees | Per-employee-per-month SaaS |
| Device Integration | CalmiGo Plus, FRENZ Brainband | $189 device + $9/mo app bundles | EEG and biofeedback creating closed-loop therapy | Hardware + subscription hybrid |
| Investment Activity | a16z, General Catalyst, Optum Ventures | $2.7B total funding in 2024; $1.32B in H1 2025 | Late-stage mega-rounds doubled; AI focus intensified | Series B multiples: 8× ARR (down from 25×) |
Get a Clear, Visual
Overview of This Market
We've already structured this market in a clean, concise, and up-to-date presentation. If you don't have time to waste digging around, download it now.
DOWNLOAD THE DECKWhat is the current landscape of top-performing mental health apps globally and who are the dominant companies behind them?
Calm maintains its revenue leadership with $300 million in 2023, supported by 4.5 million paying subscribers across 133 million lifetime downloads, while Headspace follows at $195 million with 2.8 million subscribers.
However, retention metrics reveal a different story. Insight Timer achieves 16% Day-30 retention despite generating only $48 million revenue, nearly double Calm's 8.3% retention rate. This superior engagement stems from their community-focused "meditate live" rooms and streak gamification, proving that social features significantly outperform solo meditation content.
BetterHelp generates an estimated $250 million through its teletherapy marketplace, connecting 1.5 million users with licensed therapists at $65-95 weekly rates. Talkspace follows with $138 million in 2024 revenue, focusing heavily on insurance-covered sessions with 148,000 paying members.
AI-native platforms are disrupting traditional players. Pathos raised a massive $365 million Series D in May 2025, achieving 23% beta retention through sentiment-analysis-driven personalization. Their approach combines real-time mood tracking with customized therapeutic interventions, representing the next generation of mental health apps.
Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.
Which mental health startups have raised the most funding in 2024 and 2025, how much did they raise, and who are their key investors?
Pathos leads with a $365 million Series D in May 2025, backed by Andreessen Horowitz and General Catalyst, positioning AI-driven personalized therapy as the category's next frontier.
Talkiatry secured $130 million in Series C funding in June 2024, led by Headline and Credo, specifically targeting virtual psychiatry for Medicaid populations. Spring Health raised $100 million in Series E funding in October 2024 from Insight Partners and IA Ventures, strengthening its employer behavioral health platform that serves enterprise clients.
Flow captured $100 million in Series B funding in November 2024 from an undisclosed sovereign wealth fund, building an enterprise mental health platform for large organizations. Newleos Therapeutics raised $93.5 million in Series A funding in April 2025 from NEA, developing closed-loop deep brain stimulation for treatment-resistant depression.
Precision Neuroscience secured $93 million in Series C funding in March 2025 from Alumni Ventures and Steadview Capital, advancing wireless neuro-modulation implants. Pelago raised $58 million in Series C funding in March 2024 from Atomico and Kinnevik, focusing on employer substance use disorder care programs.
These mega-rounds signal investor confidence in clinically-validated solutions with clear reimbursement pathways, particularly those targeting enterprise customers or prescription-grade interventions.
If you want fresh and clear data on this market, you can download our latest market pitch deck here
Which venture capital firms, corporate investors, or industry giants are actively backing mental health app startups, and under what conditions are they investing?
Andreessen Horowitz leads with six mental health deals in 2024-2025, including major bets on Pathos, Upheal, and Slingshot AI, focusing specifically on AI-enhanced therapeutic platforms.
General Catalyst completed five deals, backing Pathos, Solace, and Lyra Health, while Optum Ventures invested in four companies including Solace, Alma, and Spring Health. Cigna Ventures participated in three rounds for Alma, SonderMind, and Brightside, and Tiger Global backed Kintsugi, Solace, and Grow Therapy.
Corporate strategics are driving premium valuations. CVS Ventures backed Cortica, Array, and Spectrum AI to integrate behavioral care into MinuteClinic networks. UnitedHealth acquired Refresh Mental Health in 2023 for an estimated $1.2 billion and continues investing through Optum Ventures to capture longitudinal behavioral claims data.
Investment terms have shifted dramatically. Average check sizes dropped 22% from 2021 highs, while Series B valuations reset from 25× ARR multiples in 2021 to 8× ARR in 2025. Convertible SAFEs with most-favored-nation clauses now dominate seed deals to hedge macro uncertainty.
Strategic investors pay premium valuations averaging 12× ARR for data network effects, while participation rights and milestone-based tranched capital are commonplace in Series A rounds to enforce clinical outcomes reporting.
Which startups in this space have received awards or notable industry recognition recently, and what made them stand out?
CalmiGo Plus won the CES 2025 Innovation Award in Digital Health for integrating physiological sensors with gamified cognitive behavioral therapy, delivering immediate breath-guided anxiety relief through biofeedback progress tracking.
Woebot Health earned the 2024 MedTech Breakthrough Award for Mental Health Innovation by building an FDA-quality evidence base for AI chat companions delivering CBT and IPT content in low-resource settings. Health Innovation EM/Qbtech received the 2025 HSJ Digital Award for Improving Mental Health Through Digital by implementing NHS-wide ADHD digital assessment tools that cut waiting times by 153 days.
Tellmi captured the 2025 Health Tech Digital Award for Best Mental Health Tech Solution by creating a peer-moderated app for 11-25 year olds that achieved 60% anxiety score reduction in randomized controlled trials. The Linghos won the 2024 NN Social Innovation Award for connecting AI pediatric speech therapy with mental health interventions, enabling early detection and remote CBT for stuttering-related anxiety.
These award winners share common characteristics: measurable clinical outcomes, integration with existing healthcare systems, and evidence-based approaches validated through controlled studies rather than self-reported user satisfaction metrics.
The Market Pitch
Without the Noise
We have prepared a clean, beautiful and structured summary of this market, ideal if you want to get smart fast, or present it clearly.
DOWNLOADHow much total investment has flowed into mental health apps globally in 2024 and so far in 2025, and what is the forecast for 2026?
Global mental health venture funding reached $2.7 billion in 2024, representing 12% of the total $10.1 billion digital health investment, up from 9% in 2023.
The first half of 2025 generated $1.32 billion across 96 deals, suggesting annual totals could exceed $2.6 billion if current momentum continues. Deal volume increased from 157 transactions in 2023 to 184 in 2024, indicating broader investor participation despite individual check size reductions.
Mega-rounds exceeding $100 million doubled in 2025 versus 2024, as investors rotated back to proven revenue models with clear paths to profitability. Late-stage revival drove this trend, with Series C and later rounds capturing 60% of total dollars despite representing only 25% of deal count.
RootsAnalysis and Fortune Business Insights project 14-18% compound annual growth rates, implying approximately $3.1 billion in mental health venture capital for 2026. This forecast assumes no major macroeconomic shocks and continued regulatory support for digital therapeutics reimbursement.
Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.
What are the most active geographic markets for mental health apps today, and where are the key hubs for innovation and growth?
The United States dominates with 65% of funding and 58% of deals, concentrated in San Francisco Bay Area, New York City, Boston, and Austin, driven by deep venture capital pools, established payer partnerships, and FDA regulatory pathway expertise.
The United Kingdom captures 10% of global funding, led by London, Cambridge, and Manchester, supported by the NHS Innovation Accelerator program and Wellcome Trust's £20 million mental health technology fund. Canada accounts for 5% of funding across Toronto, Vancouver, and Montréal, leveraging AI research talent and federal R&D tax rebates.
The DACH region (Germany, Austria, Switzerland) represents 4% of funding, particularly in Berlin and Munich, benefiting from Digital Health Fast-Track (DiGA) reimbursement regulations that enable direct app prescriptions. Australia contributes 3% of global funding, supported by robust telehealth regulations and post-bushfire mental health stimulus programs.
Emerging hubs in Bengaluru, São Paulo, and Lagos are generating increasing seed-stage activity, focusing on culturally adapted low-cost chatbots and youth helpline applications tailored to local mental health challenges and economic constraints.
If you need to-the-point data on this market, you can download our latest market pitch deck here
Are any major tech companies or healthcare giants entering or acquiring companies in this space, and what does their involvement suggest about the future of the sector?
Teladoc Health acquired UpLift for $30 million cash in April 2025, adding insurance-billed therapy networks to BetterHelp's direct-pay model, and purchased Catapult Health for $65 million to create preventive screening funnels feeding mental health referrals.
CVS Health's Wellvana acquired CVS's MSSP ACO business assets through a stock deal with CVS retaining minority stake, expanding value-based behavioral care across 40 states. Fabric acquired Walmart's MeMD telehealth assets in 2024, gaining scalable AI triage capabilities for employer and health plan customers.
Amazon integrated Talkspace e-prescribing into Amazon Pharmacy checkout in May 2025, monetizing medication adherence data while expanding Prime ecosystem stickiness. Google positioned itself as the AI "intel layer" across healthcare systems by providing Cloud and PaLM 2 health LLM technology powering Illinois's mental health triage portal.
Apple expanded Apple Health Records API for mood logging and is rumored to acquire a small CBT journaling app specifically for Vision Pro ecosystem integration. These moves indicate Big Tech's strategy to embed mental health touchpoints throughout existing consumer and healthcare workflows rather than building standalone platforms.
This corporate involvement suggests the sector's evolution toward integrated healthcare infrastructure rather than standalone apps, with technology giants focusing on data interoperability and AI enhancement rather than direct therapeutic delivery.
What notable breakthroughs in technology or R&D have been made in 2025 for mental health apps, and what innovations are expected in 2026?
Rejoyn achieved the first FDA clearance for smartphone-based depression treatment in 2024, combining Otsuka and Click Therapeutics' cognitive behavioral therapy with external focus and motivational training, demonstrating 8-point MADRS improvements in 50% of patients.
MamaLift Plus became the first FDA-cleared digital therapeutic for postpartum depression in 2024, achieving 86% of patients showing ≥4-point EPDS improvements through AI coach "Bella" delivering daily 3-minute micro-lessons. CMS created new DMHT billing codes in January 2025, enabling reimbursement for prescription digital mental health interventions including SleepioRx and DaylightRx.
FRENZ Brainband won three CES 2025 awards for EEG-based AI-generated soundscapes delivering personalized sleep and focus enhancement. The FDA expanded Clinical Decision Support Algorithms rules in 2025 to include on-device AI depression screening, while EU AI Act Article 5 prohibitions against manipulative AI drove development of "edge AI" sentiment sensors processing data locally.
Expected 2026 innovations include multimodal LLM therapist co-pilots fine-tuned for HIPAA compliance, awaiting FDA draft guidance on clinician-in-the-loop Software as Medical Device regulations. Pilot R21 grants for these systems are scheduled for Q3 2025, suggesting commercial availability by late 2026.
Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.
We've Already Mapped This Market
From key figures to models and players, everything's already in one structured and beautiful deck, ready to download.
DOWNLOADWhich mental health app companies are showing the fastest user growth and strongest retention rates, and what strategies are they using?
Insight Timer leads growth with 28% year-over-year download increases, achieving industry-best 16% Day-30 retention through streak gamification, social "meditate live" rooms, and highly customizable meditation timers that create personalized user experiences.
Wysa demonstrates 24% year-over-year growth with 14% retention rates by embedding AI-CBT chatbots directly into insurer benefit packages and sending weekly mood reports via email to maintain engagement outside the app. Their integration strategy with healthcare payers creates sustainable user acquisition channels.
BetterHelp's B2B myStrength platform shows 10% enterprise visit growth through tiered stepped-care progression from self-help content to coaching to licensed therapy, completing over 1 million sessions in 2024. This graduated approach reduces churn by meeting users at their current readiness level.
CalmiGo Plus maintains 79% symptom reduction rates in VA pilot programs through device-integrated biofeedback progress graphs and daily reminders, achieving 3-minute average daily usage through immediate physiological feedback loops. MamaLift Plus achieves 80% eight-week program completion through daily micro-lessons and AI agent "Bella" providing personalized encouragement and content adaptation.
These retention leaders share common strategies: immediate feedback mechanisms, social or community elements, integration with existing user workflows, and progressive engagement models that adapt to individual user needs rather than one-size-fits-all approaches.
If you want actionable data about this market, you can download our latest market pitch deck here
Who are the main competitors or adjacent players in sectors like wellness or fitness that are moving into the mental health app space?
Fitness platforms are rapidly expanding mental health features. Peloton launched "Mind" meditation classes integrated into existing workout subscriptions, while Strava added mood logging to correlate emotional states with exercise patterns, leveraging their established user engagement habits.
Sleep technology companies are creating mental health adjacencies. Oura Ring opened stress score APIs enabling mental health apps to incorporate physiological stress data, while sleep-focused platforms integrate CBT-I content for anxiety-related insomnia treatment.
Women's health apps are testing mental health modules. Flo and Clue beta-tested CBT interventions specifically for PMS-linked anxiety, recognizing hormonal mood fluctuations as natural entry points for broader mental health engagement.
Corporate wellness platforms are acquiring mental health capabilities. Virgin Pulse purchased Tictrac to layer behavioral coaching and CBT content onto existing employee wellness programs, creating comprehensive mind-body health ecosystems.
Nutrition apps are expanding behavioral scope. Noom launched "Noom Mood" behavioral coaching that applies their successful habit-change methodology to emotional regulation rather than just weight management, leveraging established user behavior patterns.
Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.
What are the common business models among successful mental health apps, and which monetization strategies seem to work best in this market?
Freemium-to-subscription models dominate consumer apps, with Calm and Headspace generating $52-70 annual revenue per user through $69.99 yearly subscriptions, though 30-40% app store cuts significantly impact net revenues.
| Business Model | Key Players | Economics | Success Factors |
|---|---|---|---|
| Freemium Subscription | Calm, Headspace, Insight Timer | $52-70 ARPU annually; 30-40% platform fees | High-quality content, social features, personalization |
| Insurance-Billed Teletherapy | UpLift, Talkspace, BetterHelp | $78-102 per session; CPT codes 90837/90834 | Licensed therapist networks, payer relationships |
| Employer SaaS (PEPM) | Lyra, Modern Health, Spring Health | $5-11 per employee monthly; 18-25% margins | Clinical outcomes data, seamless HR integration |
| Prescription Digital Therapeutics | Rejoyn, MamaLift Plus, SleepioRx | ~$1,700 per treatment course; CMS DMHT codes | FDA clearance, clinical evidence, provider adoption |
| Device-App Bundle | CalmiGo Plus, FRENZ Brainband | $189 device + $9/month; 55% hardware margins | Immediate biofeedback, measurable outcomes |
| Value-Based Contracts | Spring Health, Lyra Health | Outcome guarantees (≥40% PHQ-9 improvement) | Risk-sharing, longitudinal engagement tracking |
| Marketplace Commission | BetterHelp, Talkspace | 20-30% commission on therapist sessions | Therapist supply management, quality assurance |
What regulatory or privacy considerations are impacting the mental health app market globally, and how are top companies responding to these challenges?
HIPAA-GDPR hybrid compliance requirements force dual-region apps to implement granular consent mechanisms and 6-year personal health information retention, while the FTC fined Cerebral $7.8 million in 2024 for Facebook pixel data sharing violations.
The EU AI Act Article 5 prohibits manipulative AI and social scoring systems, reclassifying mental health Software as Medical Device as "high risk" and requiring explainable AI with comprehensive audit logging. Companies respond by implementing geofenced consent modals and developing on-device AI specifically for EU users to avoid cloud data processing restrictions.
The MHRA introduced stricter Digital Mental Health Device Rules in February 2025, requiring enhanced CE/UKCA marking and clinical effectiveness proofs, with Qbtech's ADHD assessment tool gaining NHS rollout after demonstrating compliance. CMS created new DMHT billing codes in 2025, enabling reimbursement for prescription apps through three new CPT codes requiring clinician "incident-to" supervision.
State privacy acts in California, Virginia, and Colorado mandate opt-out sale/sharing provisions, prompting BetterHelp to end Facebook pixel usage after a $7 million FTC settlement in 2023 and develop in-house advertising technology. Companies increasingly adopt zero-trust architectures with end-to-end encryption and client-side data processing to maintain compliance across multiple jurisdictions.
Curious about how money is made in this sector? Explore the most profitable business models in our sleek decks.
Conclusion
Mental health technology reached an inflection point in 2024-2025, transitioning from experimental wellness apps to clinically-validated, reimbursable medical interventions.
The convergence of AI personalization, FDA regulatory approval, new CMS billing codes, and corporate healthcare integration creates unprecedented opportunities for entrepreneurs and investors willing to prioritize clinical evidence over engagement metrics, with the sector projected to reach $33 billion by 2030.
Sources
- Business of Apps - Calm Statistics
- StriveCloud - User Retention Examples
- Business of Apps - Headspace Statistics
- BH Business - BetterHelp Performance Analysis
- BH Business - Digital Mental Health Funding H1 2024
- Quick Market Pitch - Mental Health Tech Funding
- Fierce Healthcare - Digital Health Venture Funding 2024
- Galen Growth - Mental Health Investment Resurgence
- Research and Markets - Digital Mental Health Market Report
- Fortune Business Insights - Mental Health Apps Market
- Roots Analysis - Mental Health Apps Market
- BH Business - Non-Traditional Investors in Behavioral Health
- BH Business - Walmart UnitedHealth Partnership
- HLTH Community - Teladoc UpLift Acquisition
- CNBC - Teladoc UpLift Acquisition
- Forbes - Walmart Virtual Healthcare Sale
- BH Business - Big Tech in Behavioral Health
- Secure Privacy - Mental Health App Privacy Compliance
- Grove VC - CalmiGo CES Award
- Business Wire - CalmiGo CES Innovation Award
- FRENZ - CES 2025 Innovation Awards
- Woebot Health - Mental Health Innovation Award
- HSJ - Digital Awards 2025
Read more blog posts
-Mental Health Tech Business Models
-Mental Health Tech Funding Landscape
-Mental Health Tech Key Investors
-Mental Health Tech Investment Opportunities
-How Big is Mental Health Tech Market
-Mental Health Tech Innovations
-Mental Health Tech Market Problems